首页> 外文期刊>Journal of neurointerventional surgery >Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis
【24h】

Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis

机译:氰基丙烯酸正丁酯或On玛瑙栓塞治疗脑动静脉畸形的神经系统结果和治愈率:一项荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Background In the past decade, preoperative endovascular embolization of cerebral arteriovenous malformations (AVMs) became an essential tool in the treatment of these entities. With the current expansion of technology and wide incorporation of new devices, the indications for the use of endovascular embolization have expanded to include embolization for cure. This has been facilitated by the wide use of the new liquid embolic agents (ethylene-vinyl alcohol co-polymer (EVOH)) in addition to n-butyl cyanoacrylate (NBCA). The aim of this study was to review the current published literature for these two agents and report on permanent neurological injuries and cure rate.
机译:背景技术在过去的十年中,脑动静脉畸形(AVM)的术前血管内栓塞已成为治疗这些实体的重要工具。随着当前技术的扩展和新装置的广泛结合,使用血管内栓塞的适应症已经扩大到包括用于治疗的栓塞。除氰基丙烯酸正丁酯(NBCA)外,广泛使用新型液体栓塞剂(乙烯-乙烯醇共聚物(EVOH))也促进了这一点。这项研究的目的是审查有关这两种药物的最新公开文献,并报告永久性神经损伤和治愈率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号